A new BRAIN Initiative atlas showcases the diverse cell populations within the human hypothalamus, paving the way to discovering novel cellular targets for obesity and metabolic disease
Studies exploring metformin’s power to prevent prostate cancer progression have been inconclusive. Columbia research now shows that the drug has promise, but only for specific patients.
Wegovy (semaglutide) produces the greatest weight loss in teenagers, but a study by Columbia researchers finds that the trendy obesity drug is not cost-effective at its current price.
Columbia University has announced that Barbara B. Kahn, MD, is the winner of its 2021 Naomi Berrie Award for Outstanding Achievement in Diabetes Research.
Relatives of people with type 1 diabetes are 15 times more likely than the general population to develop the disease, and studies at Columbia are trying to find ways to delay or stop the process.
Columbia obstetrician/gynecologist Noelia Zork on what people need to know about gestational diabetes—who is most at risk, how it is treated, and what you can do to prevent it.
When Emma was diagnosed with type 1 diabetes at age 10, she worried she would have to give up dance. But her team at Columbia's Naomi Berrie Diabetes Center has kept her on her toes.
Ancient parts of the brain may hold secrets that help explain the drive to eat and how eating may affect brain health. Sabrina Diano, the new Institute of Human Nutrition director, is investigating.
A new study from Columbia pediatricians found that new mothers are more receptive to educational materials that contain facts, not criticism, about sugary drinks.